Patient-reported outcomes of treatment and adverse effects following acute lymphoblastic leukemia: a low- and middle-income country cross-sectional study Eduardo Cerello Chapchap; Nina Melo; Denise Martins; Maria Lucia Lee; Nelson Hamerschlak;

Treatment with low-dose tyrosine kinase inhibitors due to significant haematologic toxicity in patients with CML with prolonged treatment failure prevents haematologic progression Lucia Vráblová; Hana Klamová; Ivana Skoumalová; Jana Navrátilová; Romana Janská; Jan Grohmann; Milena Holzerová; Edgar Faber;

Survival benefit of pediatric-based regimen for adults with acute lymphoblastic leukemia: A single-center retrospective cohort Miguel Pedro de Queiroz Neto; Larissa da Costa; Erica Sabrine Angelo Lisboa; Silvia Nathalia Bueno Silva; Ana Paula de Azambuja; Elenaide Coutinho Nunes; Rodrigo Miguel Bendlin;